KKR's $390 Million Trading Day Leads to 196th Ranking as It Exits Indian Pharma with $1.4 Billion Deal

On June 30, 2025, KKR's trading volume was $390 million, a 46.09% decrease from the previous day, ranking 196th in the day's stock market. KKR's stock price fell by 1.00%.

KKR has agreed to sell its 46.39% stake in JB Chemicals & Pharmaceuticals Ltd. to Torrent Pharmaceuticals for $1.4 billion. This transaction marks a significant exit for KKR from the Indian pharmaceutical sector, as Torrent Pharmaceuticals, controlled by billionaire brothers Sudhir and Samir Mehta, aims to expand its market presence. The deal involves Torrent Pharmaceuticals acquiring the stake at 1,600 rupees per share, with JB Pharma shareholders receiving 51 Torrent shares for every 100 JB Pharma shares held upon merger. This acquisition is notable as it is the second-largest in India's pharmaceutical history, underscoring Torrent's strategic play in the market.